BTIG upgraded Aclaris Therapeutics (ACRS) to Buy from Neutral with an $8 price target In a “transformative transaction,” Aclaris has acquired ...

Fintel reports that on November 18, 2024, BTIG initiated coverage of VYNE Therapeutics (NasdaqCM:VYNE) with a Buy ...

BTIG raised the firm’s price target on Syndax (SNDX) to $43 from $35 and keeps a Buy rating on the shares. The firm cites the company having ...

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its Digital Health Forum will take place on Monday, November 25, 2024. The event will be hosted by David Larsen, CFA, BTIG Healthcare IT and ...

On Friday, Synchrony Financial (SYF) stock saw a modest uptick, ending the day at $64.98 which represents a slight increase of $0.09 or 0.14% from the prior close of $64.89. The stock opened at $64.99 ...

On Thursday, Opendoor Technologies Inc (OPEN) stock saw a decline, ending the day at $1.77 which represents a decrease of $-0.04 or -2.21% from the prior close of $1.81. The stock opened at $1.81 and ...

"The bond market is telling you that Trump's policies will be inflationary and you're going to have tariffs, so the direction of the 10-year yield is going to be the indicator for how the small caps ...

Plug Power downgraded at BTIG Research, citing need for more product sales to boost margins in the hydrogen market.

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

On Tuesday, BTIG updated their assessment of Glaukos Corporation (NYSE:GKOS), increasing the price target to $140 from $139 while maintaining a Buy rating. This adjustment follows Glaukos' third ...

Fintel reports that on November 4, 2024, BTIG downgraded their outlook for Fiverr International (NYSE:FVRR) from Buy to ...

On Monday, Dream Finders Homes Inc. (NYSE:DFH) shares maintained Neutral rating by BTIG, following a third-quarter earnings per share (EPS) that fell short of expectations. Dream Finders Homes ...